Daniel R. Kuritzkes, MD

Daniel R. Kuritzkes, MD received his BS and MS degrees in Molecular Biophysics and Biochemistry from Yale University, and his MD from Harvard Medical School.  He completed his clinical and research training in internal medicine and infectious diseases at Massachusetts General Hospital and was a visiting scientist at the Whitehead Institute for Biomedical Research before joining the faculty at the University of Colorado Health Sciences Center.  Dr. Kuritzkes returned to Harvard Medical School in 2002, where he is Professor of Medicine and Chief, Division of Infectious Diseases at Brigham and Women’s Hospital. 

 

Dr. Kuritzkes has published extensively on antiretroviral therapy and drug resistance in HIV-1 infection.  He has chaired several multicenter studies of HIV therapy and currently serves as Principal Investigator and Chair of the AIDS Clinical Trials Group.  He has served on numerous NIH committees and currently is a member of the NIH Office of AIDS Research Advisory Council He has been a member of several editorial boards, and serves as an Associate Editor of the Journal of Infectious Diseases.  He is a former member of the Department of Health and Human Services panel on guidelines for antiretroviral therapy and a past Chair of the HIV Medicine Association Board of Directors.  His research interests focus on antiretroviral therapy, drug resistance and HIV eradication.